SEC Contract Filing

Filing Date: 2024-01-02

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT
MEDICAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
29, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder
of Preferred Investment Options Issued in October 2022 and June 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:
<U>Inducement Offer to Exercise Preferred Investment Options Issued in October 2022 and June 2023</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical Inc. (the &ldquo;<U>Company</U>&rdquo;) is pleased to offer to you (&ldquo;<U>Holder</U>&rdquo;, &ldquo;<U>you</U>&rdquo; or
similar terminology) the opportunity to receive (a) new preferred investment options to purchase shares of the Company&rsquo;s common
stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;), and (b) a reduction in the Exercise Price (as defined in the
respective Existing Preferred Investment Options) of the preferred investment options to purchase an aggregate of [___] shares of Common
Stock held by you in consideration for exercising for cash all of the Company&rsquo;s [(i) Series A preferred investment options to purchase
an aggregate of [___] shares of Common Stock, issued to you on October 25, 2022, as amended on May 24, 2023 (at an amended exercise price
of $2.20 per share), [(ii) Series C preferred investment options to purchase an aggregate of [___] shares of Common Stock, issued to
you on June 6, 2023 (at an original exercise price of $2.075 per share) and [(iii) Series D preferred investment options to purchase
an aggregate of [___] shares of Common Stock, issued to you on June 26, 2023 (at an original exercise price of $3.19 per share) (clauses
(i) through (iii) collectively, the &ldquo;<U>Existing Preferred Investment Options</U>&rdquo;)], as set forth on the signature page
hereto. The issuance and/or resale of the shares of Common Stock underlying the Existing Preferred Investment Options (the &ldquo;<U>Existing
Preferred Investment Option Shares</U>&rdquo;) have been registered pursuant to the registration statement on Form S-1 (File No. 333-273207)
(the &ldquo;<U>Registration Statement</U>&rdquo;). The Registration Statement is currently effective and, upon exercise of the Existing
Preferred Investment Options pursuant to this letter agreement, will be effective for the issuance and resale of the Existing Preferred
Investment Option Shares, as applicable. Capitalized terms not otherwise defined herein shall have the meanings set forth in the New
Preferred Investment Options (as defined herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company desires to reduce the Exercise Price (as defined in the respective Existing Preferred Investment Options) of the Existing Preferred
Investment Options to $1.62 per share (the &ldquo;<U>Reduced Exercise Price</U>&rdquo;). In consideration for cash exercising in full
all of the Existing Preferred Investment Options held by Holder as set forth on the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant
Exercise</U>&rdquo;) at the Reduced Exerc